The purpose of this trial is to study: * Effects of arzoxifene on bone fractures and bone mass. * Effects of arzoxifene on getting breast cancer. * Effects of arzoxifene on certain types of cardiovascular events, such as heart attack and stroke. * Effects of arzoxifene that changes the amount of certain substances in the blood that are related to osteoporosis and cardiovascular health. * Effects of arzoxifene on the uterus. * The safety of arzoxifene and any side effects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
9,369
20mg, oral, tablet, once a day for 36 months
oral, tablet, once a day for 36 months
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Elk Grove, Illinois, United States
Effects of arzoxifene on bone fractures and bone mass
Time frame: 5 years
Effects of arzoxifene on getting breast cancer
Time frame: 5 years
The safety of arzoxifene and any side effects
Time frame: 5 years
Effects of arzoxifene on certain types of cardiovascular events
Time frame: 5 years
Effects of arzoxifene that changes the amount of certain substances in the blood that are related to osteoporosis and cardiovascular health
Time frame: 5 years
Effects of arzoxifene on the uterus
Time frame: 5 years
Effects of arzoxifene on cognition
Time frame: 5 years
Effects of arzoxifene on back pain
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.